The central lab industry is on a rapid ascent, with a projected valuation of nearly US$2.42 billion in 2022. Thanks to the expanding landscape of global clinical trials, this industry is slated for strong growth, boasting an anticipated Compound Annual Growth Rate (CAGR) of approximately 6% from 2022 to 2032. By the end of 2032, …